BR 111A
Alternative Names: BR-111ALatest Information Update: 30 Jun 2023
At a glance
- Originator Hisun BioRay
- Class Antineoplastics; Bispecific antibodies; Drug conjugates; Immunoconjugates
- Mechanism of Action Receptor tyrosine kinase-like orphan receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Haematological malignancies; Solid tumours